FDA redefines 510(k) special controls

Noting the confusion over the updated 510(k) clearance process, the FDA has released a clarification of the rules governing Class II medical devices, especially the "special controls" designated by the governing body. The agency also has scheduled a public workshop to discuss clinical trial requirements.

"In order to comply with the special controls guidance, manufacturers must address each identified risk to health presented in the guidance for the Class II device by either meeting the recommendations of the guidance or by some other means that provides equivalent assurances of safety and effectiveness," the FDA said, according to MassDevice. According to the FDA, those special controls can include labeling requirements, performance standards and continual follow-up on the devices.

- read the MassDevice piece

Suggested Articles

The spine surgery company ATEC has moved to acquire Paris-based EOS imaging, makers of FDA-cleared scanners and 3D orthopedic planning software.

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.

Ortho Clinical Diagnostics has launched a new chemistry system to complete its integrated Vitros XT line of laboratory solutions.